HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lan Li Selected Research

Ischemia

1/2024The mitochondria‒paraspeckle axis regulates the survival of transplanted stem cells under oxidative stress conditions.
12/2021Restoring Cardiac Functions after Myocardial Infarction-Ischemia/Reperfusion via an Exosome Anchoring Conductive Hydrogel.
10/2020Ginsenoside Rg3-loaded, reactive oxygen species-responsive polymeric nanoparticles for alleviating myocardial ischemia-reperfusion injury.
12/2019Injectable extracellular vesicle-released self-assembling peptide nanofiber hydrogel as an enhanced cell-free therapy for tissue regeneration.
1/2018Neural Stem Cell-Conditioned Medium Ameliorated Cerebral Ischemia-Reperfusion Injury in Rats.
7/2015Localized lower extremity ischemic preconditioning prevents against local thrombus formation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lan Li Research Topics

Disease

89Neoplasms (Cancer)
02/2024 - 08/2003
62Inflammation (Inflammations)
08/2023 - 03/2007
34Infections
05/2024 - 09/2010
17Breast Neoplasms (Breast Cancer)
01/2024 - 01/2017
17Fibrosis (Cirrhosis)
05/2022 - 03/2011
16Atherosclerosis
11/2023 - 02/2004
16Asthma (Bronchial Asthma)
10/2023 - 12/2006
15Mitochondrial Diseases (Mitochondrial Disease)
07/2023 - 01/2015
15Reperfusion Injury
01/2023 - 01/2012
12Body Weight (Weight, Body)
04/2023 - 09/2004
11Heart Failure
11/2023 - 01/2016
11Insulin Resistance
10/2023 - 09/2002
10Hypertension (High Blood Pressure)
02/2024 - 01/2006
10Hepatocellular Carcinoma (Hepatoma)
11/2022 - 02/2008
9Neoplasm Metastasis (Metastasis)
05/2024 - 03/2002
9Pancreatitis
08/2023 - 01/2020
9Obesity
01/2023 - 08/2010
9Carcinoma (Carcinomatosis)
01/2023 - 03/2002
9Acute Kidney Injury (Acute Renal Failure)
12/2022 - 07/2018
9Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2022 - 06/2018
8Dry Eye Syndromes (Dry Eye Syndrome)
01/2023 - 01/2019
8Uterine Cervical Neoplasms (Cancer of the Cervix)
12/2022 - 07/2013
8Brain Ischemia (Cerebral Ischemia)
07/2022 - 01/2012
7Stomach Neoplasms (Stomach Cancer)
05/2024 - 08/2006
7Wounds and Injuries (Trauma)
03/2024 - 01/2015
7Necrosis
08/2023 - 09/2007
7Pancreatic Neoplasms (Pancreatic Cancer)
01/2023 - 11/2004
7Liver Cirrhosis (Hepatic Cirrhosis)
05/2022 - 02/2009
6COVID-19
05/2024 - 08/2021
6Ischemia
01/2024 - 07/2015
6Colorectal Neoplasms (Colorectal Cancer)
07/2023 - 04/2007
6Pain (Aches)
01/2023 - 02/2017
6Carcinogenesis
01/2023 - 12/2009
6Hemorrhage
01/2023 - 03/2011
6Sepsis (Septicemia)
06/2022 - 01/2020
6Fatty Liver
01/2020 - 02/2006
6Cysts
08/2019 - 09/2015
5Hypoxia (Hypoxemia)
02/2024 - 08/2015
5Osteoporosis
01/2024 - 12/2021
5Mental Disorders (Mental Disorder)
01/2024 - 07/2015
5Ulcer
12/2023 - 09/2012
5Critical Illness (Critically Ill)
12/2023 - 01/2021
5Edema (Dropsy)
11/2023 - 05/2014
5Respiratory Sounds (Crackle)
11/2023 - 06/2013
5Non-alcoholic Fatty Liver Disease
11/2023 - 02/2017
5Myocardial Ischemia (Ischemic Heart Diseases)
01/2023 - 01/2015
5Metabolic Syndrome (Dysmetabolic Syndrome X)
11/2022 - 02/2011
5Multiple Myeloma
08/2022 - 01/2019

Drug/Important Bio-Agent (IBA)

47Proteins (Proteins, Gene)FDA Link
05/2024 - 08/2003
25Biomarkers (Surrogate Marker)IBA
01/2024 - 02/2010
20Messenger RNA (mRNA)IBA
02/2024 - 02/2012
15CytokinesIBA
04/2022 - 01/2006
14Therapeutic UsesIBA
01/2024 - 02/2009
14LipidsIBA
05/2023 - 08/2010
10EnzymesIBA
05/2024 - 11/2004
9Glucose (Dextrose)FDA LinkGeneric
01/2023 - 08/2010
9Interleukin-6 (Interleukin 6)IBA
01/2022 - 06/2014
9CollagenIBA
01/2022 - 02/2012
8RNA (Ribonucleic Acid)IBA
01/2023 - 12/2019
8Interleukin-10 (Interleukin 10)IBA
09/2020 - 08/2008
7ChemokinesIBA
01/2024 - 01/2015
7AntigensIBA
01/2024 - 02/2008
7Cisplatin (Platino)FDA LinkGeneric
01/2023 - 11/2017
7HydrogelsIBA
01/2023 - 11/2018
7Peptides (Polypeptides)IBA
11/2021 - 02/2008
6MicroRNAs (MicroRNA)IBA
10/2023 - 10/2017
6AlbuminsIBA
12/2022 - 01/2018
6InterleukinsIBA
10/2022 - 03/2011
6Reactive Oxygen Species (Oxygen Radicals)IBA
08/2022 - 01/2018
6C-Reactive ProteinIBA
01/2022 - 02/2004
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021 - 04/2007
6Triglycerides (Triacylglycerol)IBA
01/2020 - 02/2006
6CurcuminIBA
01/2017 - 11/2004
6Cyclooxygenase 2 (Cyclooxygenase-2)IBA
08/2007 - 11/2004
5VaccinesIBA
12/2023 - 03/2016
5LipopolysaccharidesIBA
10/2023 - 01/2019
5CholesterolIBA
01/2023 - 01/2016
5LigandsIBA
12/2022 - 07/2013
5Transcription Factors (Transcription Factor)IBA
11/2022 - 11/2004
5Long Noncoding RNAIBA
10/2022 - 10/2018
5Caspase 3 (Caspase-3)IBA
01/2022 - 01/2012
5VancomycinFDA LinkGeneric
01/2022 - 09/2018
5OvalbuminIBA
01/2022 - 11/2019
5Antiviral Agents (Antivirals)IBA
01/2022 - 05/2013
5Aspartate Aminotransferases (Aspartate Transaminase)IBA
06/2021 - 09/2010
5Transforming Growth Factors (Transforming Growth Factor)IBA
01/2020 - 04/2015
5Apolipoproteins E (ApoE)IBA
12/2019 - 02/2004
5Small Interfering RNA (siRNA)IBA
01/2018 - 03/2007
5NF-kappa B (NF-kB)IBA
11/2017 - 11/2004
5AutoantibodiesIBA
06/2017 - 04/2003

Therapy/Procedure

60Therapeutics
05/2024 - 11/2008
15Radiotherapy
01/2023 - 11/2016
14Drug Therapy (Chemotherapy)
12/2022 - 04/2007
10Immunotherapy
02/2024 - 04/2008
8Transplantation
11/2023 - 06/2008
8Aftercare (After-Treatment)
11/2023 - 02/2009
7Injections
01/2023 - 11/2010
6Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2024 - 05/2013
5Length of Stay
01/2022 - 09/2012
5Ligation
01/2022 - 03/2011